Clinical Study
Steroid-Refractory Acute GVHD: Predictors and Outcomes
Table 1
Patients and transplant characteristics.
| Characteristic | Value (%) |
| No. of patients | 287 | | Patient age | | | Median, y (range) | 45 | (19–72) | Older than 40 y | 138 | (48) | 40 y or younger | 149 | (52) | Median no. of prior chemotherapy lines (range) | 2 | (0–9) |
| Donor/patient sex mismatch | | | Female Donor/Male Patient | 73 | (25) | Other | 214 | (75) |
| Diagnosis | | | Lymphoid | 163 | (57) | Myeloid | 100 | (35) | Multiple myeloma | 8 | (3) | Solid tumor | 4 | (1) | Other | 12 | (4) |
| Disease status at transplantation | | | Not in remission | 188 | (66) | Remission | 99 | (34) |
| Donor type | | | Matched | 251 | (88) | Mismatched | 36 | (12) |
| Cell source | | | Peripheral Blood | 126 | (44) | Bone Marrow | 161 | (56) |
| Conditioning regimen | | | Reduced intensity | 102 | (35.5) | High-dose chemotherapy | 137 | (50.5) | High-dose chemotherapy/TBI | 48 | (13.9) |
|
|